Lab-Grown immune cells take on dangerous viruses in vulnerable patients
NCT ID NCT02479698
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether specially grown donor immune cells (called cytotoxic T lymphocytes) can safely and effectively control BK and JC virus infections in people with weakened immune systems, such as those with cancer, HIV, or organ transplants. About 100 participants will receive these cells and be monitored for response and side effects. The goal is to reduce the virus and prevent complications, not to cure the underlying condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED IMMUNODEFICIENCY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cord blood t cells be trained to stop viral infections after transplant?
- Walking groups could shield HIV-Positive latino men from heart disease
- Can specially grown immune cells from donors beat viruses that won't go away?
- Friends helping friends: a novel social-network strategy to boost HIV prevention
- Blood test may one day personalize drug dosing after stem cell transplants
- Could a lighter immunotherapy schedule keep advanced cancers in check?